Lyon (France), and Cambridge, MA (US) May 24, 2023 – ERYTECH Pharma (Euronext & Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drugs in red blood cells (RBCs), announces today the procedures for making available the preparatory documents for the Combined General Meeting of June 23, 2023.
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected]